Source: BioPortfolio

Chondrial Therapeutics: Chondrial Therapeutics Raises Up to $22.6M in Series A Financing

NewsThe core technology is based on intellectual property owned by Wake Forest Baptist Medical Center and licensed through its commercialization arm.Topics

Read full article »
Chondrial Therapeutics's Competitors | Chondrial Therapeutics's News | Chondrial Therapeutics's Financials
Stay up-to-date with the latest news on Chondrial Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Carole Ben-Maimon's photo - President & CEO of Chondrial Therapeutics

President & CEO

Carole Ben-Maimon

CEO Approval Rating

87/100

Read more
Stay up-to-date with the latest news on Chondrial Therapeutics